For instance, FLT3ITD TET2 (1, 5), FLT3ITDDNMT3A (2), DNMT3A TET2 (6, 7), or FLT3ITD NPM1 (8) mutations frequently coexist in normal CN patients with AML (9–11). Here, DNMT3A is linked to acute myeloid leukemia.